These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 18820228)

  • 1. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study: response to Yeh et al.
    Teeter JG; Riese RJ
    Diabetes Care; 2008 Oct; 31(10):e82. PubMed ID: 18820228
    [No Abstract]   [Full Text] [Related]  

  • 2. Cross-sectional and prospective study of lung function in adults with type 2 diabetes: the Atherosclerosis Risk in Communities (ARIC) study.
    Yeh HC; Punjabi NM; Wang NY; Pankow JS; Duncan BB; Cox CE; Selvin E; Brancati FL
    Diabetes Care; 2008 Apr; 31(4):741-6. PubMed ID: 18056886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study].
    Comaschi MA; Menozzi F
    Ital Heart J Suppl; 2000 Nov; 1(11):1491-3. PubMed ID: 11109203
    [No Abstract]   [Full Text] [Related]  

  • 4. [Modern views of diabetic angiopathy of the lower limbs (epidemiology, risk factor, etiopathogenesis, atherosclerosis of diabetes mellitus). Part I].
    Losev RZ; Kulikova AN
    Angiol Sosud Khir; 2005; 11(3):14-20. PubMed ID: 16439944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Where and in which blood vessels does atherosclerosis manifest itself?].
    Skowasch D; Bauriedel G
    Dtsch Med Wochenschr; 2005 Dec; 130(48):2789. PubMed ID: 16307410
    [No Abstract]   [Full Text] [Related]  

  • 6. Impact of white-coat hypertension on microvascular complications in type 2 diabetes: response to Kramer et al.
    Eguchi K; Kario K
    Diabetes Care; 2009 Feb; 32(2):e24; author reply e25. PubMed ID: 19171733
    [No Abstract]   [Full Text] [Related]  

  • 7. Association of serum resistin with TNF system activity in Japanese type 2 diabetic patients.
    Kitatani N; Taniguchi A; Fukushima M; Nakai Y; Nagasaka S; Ohgushi M; Ohya M; Kuroe A; Inagaki N; Seino Y
    Diabetes Metab; 2007 Apr; 33(2):156-7. PubMed ID: 17392006
    [No Abstract]   [Full Text] [Related]  

  • 8. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients: response to Targher et al. and Hu et al.
    Talim M
    Diabetes Care; 2007 Jun; 30(6):e55; author reply e56. PubMed ID: 17526817
    [No Abstract]   [Full Text] [Related]  

  • 9. Valvular calcification and its relationship to atherosclerosis in chronic kidney disease.
    Leskinen Y; Paana T; Saha H; Groundstroem K; Lehtimäki T; Kilpinen S; Huhtala H; Airaksinen J
    J Heart Valve Dis; 2009 Jul; 18(4):429-38. PubMed ID: 19852148
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal liver function test predicts type 2 diabetes: a community-based prospective study: response to Cho et al.
    Huang JF; Dai CY; Yu ML; Hsieh MY; Chuang WL
    Diabetes Care; 2008 Jun; 31(6):e53. PubMed ID: 18509140
    [No Abstract]   [Full Text] [Related]  

  • 11. [Risk factor hyperinsulinemia? Contra!].
    Ratzmann KP
    Dtsch Med Wochenschr; 2000 May; 125(21):678-80. PubMed ID: 10874908
    [No Abstract]   [Full Text] [Related]  

  • 12. Pantalone et al.: the risk of developing coronary artery disease or congestive heart failure, and overall mortality, in type 2 diabetic patients receiving rosiglitazone, pioglitazone, metformin, or sulfonylureas: a retrospective analysis.
    Bell DS
    Acta Diabetol; 2009 Jun; 46(2):155; author reply 157. PubMed ID: 19300899
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of genetic risk in three candidate genes (TCF7L2, PPARG, KCNJ11) with traditional risk factors for type 2 diabetes in a population-based study--the HUNT study.
    Thorsby PM; Midthjell K; Gjerlaugsen N; Holmen J; Hanssen KF; Birkeland KI; Berg JP
    Scand J Clin Lab Invest; 2009; 69(2):282-7. PubMed ID: 18972257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetic nephropathy and risk factors for peripheral artery disease in Chinese with type 2 diabetes mellitus.
    Hsieh MC; Tien KJ; Perng DS; Hsiao JY; Chang SJ; Liang HT; Chen HC; Tu ST
    Metabolism; 2009 Apr; 58(4):504-9. PubMed ID: 19303971
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retinopathy in type 2 diabetes mellitus is associated with increased intima-media thickness and endothelial dysfunction.
    Malecki MT; Osmenda G; Walus-Miarka M; Skupien J; Cyganek K; Mirkiewicz-Sieradzka B; damek-Guzik TA; Guzik TJ; Sieradzki J
    Eur J Clin Invest; 2008 Dec; 38(12):925-30. PubMed ID: 19021717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Epidemiology of arteriosclerosis in diabetes mellitus].
    Panzram G
    Verh Dtsch Ges Inn Med; 1987; 93():427-33. PubMed ID: 3327293
    [No Abstract]   [Full Text] [Related]  

  • 17. [Atheroma of the carotid in the diabetic: frequency and clinical expression in a population of 68 diabetics in Benin].
    Houénassi DM; Tchabi Y; Amoussouguénou KD; Djrolo F; Azondékon A; Sacca-Véhounkpé J; Akindès-Dossou Yovo R; Dossou Togbé F; Massougbodji-d'Almeida M; Agboton H
    J Mal Vasc; 2007 Jul; 32(3):159-61. PubMed ID: 17566680
    [No Abstract]   [Full Text] [Related]  

  • 18. Association between reduced pulmonary diffusing capacity and cardiac autonomic dysfunction in Type 1 diabetes.
    Pitocco D; Santangeli P; Fuso L; Zaccardi F; Longobardi A; Infusino F; Incalzi RA; Lanza GA; Crea F; Ghirlanda G
    Diabet Med; 2008 Nov; 25(11):1366-9. PubMed ID: 19046231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Frequency of diabetic microangiopathy in newly diagnosed diabetes mellitus in Conakry: late diagnosis and lack of screening].
    Baldé NM; Kaba ML; Baldé MD; Diallo AO; Goépogui A; Diakité M
    Dakar Med; 2007; 52(3):165-70. PubMed ID: 19097396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of serum gamma-glutamyltransferase to atherogenic dyslipidemia and glycemic control in type 2 diabetes.
    Zoppini G; Targher G; Trombetta M; Lippi G; Muggeo M
    Obesity (Silver Spring); 2009 Feb; 17(2):370-4. PubMed ID: 19057528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.